“C-Terminal-PEDF Reduces IC50 Doses and Chemoresistant Population of CD133 and BCRP1-Positve Cancer Stem Like Cells”. 2013. Journal of Analytical Oncology 2 (4): 195-208. https://doi.org/10.6000/1927-7229.2013.02.04.2.